Depression Screening

LISA SCHULMEISTER, MN, RN, ACNS-BC, OCN, FAAN
Monday, September 08, 2014
Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
A few years ago, the Institute of Medicine (IOM) suggested that ample psychosocial resources are available to people with cancer; however, clinicians are not optimizing these resources. Researchers in Scotland examined data from 21,151 patients with breast, lung, colorectal, genitourinary, or GYN cancer who had participated in routine screening for depression between May 12, 2008, and Aug 24, 2011. Depression screening was done in two stages (completion of the Hospital Anxiety and Depression Scale followed by the major depression section of the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition). Data from the depression screening were linked with demographic and clinical data obtained from the Scottish National Cancer Registry.

Major depression was highest in patients with lung cancer (13%), followed by GYN cancer (11%), breast cancer (9%), colorectal cancer (7%), and genitourinary cancer (6%). Within these groups, a diagnosis of major depression occurred more often among patients who were younger and had higher social isolation scores. Women with lung cancer and colorectal cancer also had higher rates of depression. Most importantly, the researchers found that 1,130 (73%) of 1,538 patients with diagnosed depression were not receiving potentially effective treatment, which supports the observations of the IOM.

Reference

Walter J et al. Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: A cross-sectional analysis of routinely collected clinical data. Lancet Psychiatr 2014; DOI:10.1016/S2215-0366(14)70313-X.

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN
 
Blog Info
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN is an oncology nursing consultant and editor-in-chief of Oncology Nursing News.
Author Bio
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN, is the Editor-in-Chief for OncLive Nursing. She is an oncology nursing consultant and adjunct assistant professor of nursing at Louisiana State Health Sciences Center in New Orleans, LA. She provides continuing nursing education to nurses across the Unites States, is active in several professional nursing organizations, and is intrigued by the many ways nurses use technology to communicate.
 
 
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.